We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
+13.93%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.19B
AUM Growth
+$22.1M
(+1.9%)
Cap. Flow
-$83.9M
Cap. Flow
% of AUM
-7.06%
Top 10 Holdings %
Top 10 Hldgs %
3.97%
Holding
2,047
New
610
Increased
399
Reduced
421
Closed
613
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aon
AON
|
+$5.03M |
| 2 |
Aclaris Therapeutics
ACRS
|
+$4.73M |
| 3 |
UnitedHealth
UNH
|
+$4.35M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$4.05M |
| 5 |
Remitly
RELY
|
+$3.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teck Resources
TECK
|
+$5.81M |
| 2 |
Adobe
ADBE
|
+$4.57M |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$4.14M |
| 4 |
Progyny
PGNY
|
+$4.14M |
| 5 |
Constellation Brands
STZ
|
+$3.83M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.56% |
| 2 | Technology | 13.55% |
| 3 | Consumer Discretionary | 13.11% |
| 4 | Financials | 12.97% |
| 5 | Industrials | 10.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Hillman Solutions
HLMN
$1.79B
| $135K | 0.01% |
+14,650
| New | +$112K |
|
1377
Imperial Petroleum
IMPP
$208M
| $134K | 0.01% |
50,863
-14,719
| -22% | -$27K |
|
1378
WisdomTree
WT
$3.22B
| $134K | 0.01% |
+19,329
| New | +$128K |
|
|
CIM
1379
Chimera Investment
CIM
$1B
| $133K | 0.01% |
+8,856
| New | +$134K |
|
1380
Crescent Energy
CRGY
$3.82B
| $133K | 0.01% |
+10,051
| New | +$118K |
|
1381
GrafTech
EAF
$212M
| $131K | 0.01% |
+5,972
| New | +$169K |
|
|
TTOO
1382
DELISTED
T2 Biosystems, Inc
TTOO
| $129K | 0.01% |
20,572
-5,224
| -20% | -$39.9K |
|
|
CDMO
1383
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $122K | 0.01% |
18,733
-21,285
| -53% | -$137K |
|
1384
Larimar Therapeutics
LRMR
$432M
| $115K | 0.01% |
25,232
-63,981
| -72% | -$216K |
|
1385
Vivid Seats
SEAT
$85.4M
| $111K | 0.01% |
877
-18,130
| -95% | -$2.48M |
|
1386
SiriusXM
SIRI
$10.1B
| $109K | 0.01% |
1,988
-16,354
| -89% | -$786K |
|
1387
Prime Medicine
PRME
$559M
| $108K | 0.01% |
+12,195
| New | +$94K |
|
|
FINV
1388
FinVolution Group
FINV
$1.15B
| $107K | 0.01% |
+21,805
| New | +$104K |
|
1389
Recursion Pharmaceuticals
RXRX
$1.73B
| $107K | 0.01% |
+10,860
| New | +$77.4K |
|
1390
Cullinan Oncology
CGEM
$1.14B
| $104K | 0.01% |
+10,246
| New | +$90.8K |
|
1391
Latham Group
SWIM
$880M
| $103K | 0.01% |
+39,341
| New | +$97.4K |
|
1392
Inseego
INSG
$90.5M
| $100K | 0.01% |
45,357
-114,930
| -72% | -$346K |
|
1393
Valens Semiconductor
VLN
$188M
| $100K | 0.01% |
+40,885
| New | +$94.7K |
|
1394
ChargePoint
CHPT
$161M
| $99K | 0.01% |
+2,105
| New | +$118K |
|
|
EB
1395
DELISTED
Eventbrite
EB
| $99K | 0.01% |
11,834
-39,450
| -77% | -$319K |
|
1396
Altisource Portfolio Solutions
ASPS
$65.8M
| $97K | 0.01% |
3,419
+1,760
| +106% | +$55.8K |
|
1397
Vroom Inc
VRM
$48.2M
| $97K | 0.01% |
2,018
-3,361
| -62% | -$219K |
|
|
ZUO
1398
DELISTED
Zuora, Inc.
ZUO
| $97K | 0.01% |
+10,348
| New | +$85.4K |
|
|
VWE
1399
DELISTED
Vintage Wine Estates, Inc. Common Stock
VWE
| $96K | 0.01% |
190,479
-602,288
| -76% | -$343K |
|
1400
CorMedix
CRMD
$584M
| $93K | 0.01% |
+24,721
| New | +$85.1K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q4 2023 Portfolio in Review
As of Q4 2023, GSA Capital Partners held 2,047 positions worth $1.19B, up 1.9% from $1.17B the previous quarter. Its ten largest holdings account for 4% of the portfolio.
GSA Capital Partners withdrew a net $83.9M in Q4 2023, closing 613 positions and reducing 421 holdings. Its most notable exit was Teck Resources, an estimated $5.81M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, GSA Capital Partners opened a new position in Aon worth $4.58M.
- GSA Capital Partners's largest Q4 2023 buy was Aon: 15,721 shares worth $4.58M.
- GSA Capital Partners added most to Aclaris Therapeutics in Q4 2023, an estimated $4.73M increase.
- GSA Capital Partners's biggest Q4 2023 reduction was NVIDIA, cutting an estimated $3.48M.
- GSA Capital Partners fully exited Teck Resources in Q4 2023, selling an estimated $5.81M.
- GSA Capital Partners's ten largest holdings make up 4% of its $1.19B portfolio in Q4 2023.
- GSA Capital Partners opened 610 new positions and closed 613 in Q4 2023.
- GSA Capital Partners's portfolio value rose 1.9% quarter-over-quarter to $1.19B.
Based on GSA Capital Partners's 13F filing for Q4 2023, filed 16 Feb 2024.